Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Elshorbagy A.Lyons, Alexander R.M.Alexander R.M.LyonsVallejo-Vaz, Antonio J.Antonio J.Vallejo-VazStevens, Christophe A.TChristophe A.TStevensDharmayat, Kanika I.Kanika I.DharmayatBrandts, JuliaJuliaBrandtsCatapano, Alberico L.Alberico L.CatapanoFreiberger, TomasTomasFreibergerHovingh, G. KeesG. KeesHovinghMata, PedroPedroMataRaal, Frederick J.Frederick J.RaalSantos, Raul D.Raul D.SantosSoran, HandreanHandreanSoranWatts, Gerald F.Gerald F.WattsTA-CHEN SU2024-12-042024-12-042024-11-0122138587https://scholars.lib.ntu.edu.tw/handle/123456789/723528trueAssociation of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional studyjournal article2-s2.0-85207124416